• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心型肥胖与冠心病患者的生存:文献系统评价及个体受试者数据的协作分析。

Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data.

机构信息

Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

出版信息

J Am Coll Cardiol. 2011 May 10;57(19):1877-86. doi: 10.1016/j.jacc.2010.11.058.

DOI:10.1016/j.jacc.2010.11.058
PMID:21545944
Abstract

OBJECTIVES

The aim of this study was to examine the association of central (waist circumference [WC] and waist-hip ratio [WHR]) and total obesity (body mass index [BMI]) measures with mortality in coronary artery disease (CAD) patients.

BACKGROUND

The question of which measure of obesity better predicts survival in patients with CAD is controversial.

METHODS

We searched OVID/Medline, EMBASE, CENTRAL, and Web of Science from 1980 to 2008 and asked experts in the field for unpublished data meeting inclusion criteria, in which all subjects had: 1) CAD at baseline; 2) measures of WC or WHR; 3) mortality data; and 4) a minimum follow-up of 6 months.

RESULTS

From 2,188 studies found, 6 met inclusion criteria. We obtained individual subject data from 4, adding unpublished data from a cardiac rehabilitation cohort. A variable called "central obesity" was created on the basis of tertiles of WHR or WC. Cox-proportional hazards were adjusted for age, sex, and confounders. The final sample consisted of 15,923 subjects. There were 5,696 deaths after a median follow-up of 2.3 (interquartile range 0.5 to 7.4) years. Central obesity was associated with mortality (hazard ratio [HR]: 1.70, 95% confidence interval [CI]: 1.58 to 1.83), whereas BMI was inversely associated with mortality (HR: 0.64, 95% CI: 0.59 to 0.69). Central obesity was also associated with higher mortality in the subset of subjects with normal BMI (HR: 1.70, 95% CI: 1.52 to 1.89) and BMI ≥30 kg/m(2) (HR: 1.93, 95% CI: 1.61 to 2.32).

CONCLUSIONS

In subjects with CAD, including those with normal and high BMI, central obesity but not BMI is directly associated with mortality.

摘要

目的

本研究旨在探讨中心性肥胖(腰围[WC]和腰臀比[WHR])和全身肥胖(体重指数[BMI])指标与冠心病(CAD)患者死亡率的关系。

背景

关于哪种肥胖指标能更好地预测 CAD 患者的生存率,目前仍存在争议。

方法

我们检索了 1980 年至 2008 年的 OVID/Medline、EMBASE、CENTRAL 和 Web of Science,并向该领域的专家询问了符合纳入标准的未发表数据,这些数据均满足以下标准:1)基线时患有 CAD;2)有 WC 或 WHR 测量值;3)有死亡率数据;4)随访时间至少 6 个月。

结果

从 2188 项研究中,我们找到了 6 项符合纳入标准的研究。我们从 4 项研究中获取了个体患者数据,并增加了来自心脏康复队列的未发表数据。根据 WHR 或 WC 的三分位数创建了一个名为“中心性肥胖”的变量。Cox 比例风险模型调整了年龄、性别和混杂因素。最终样本包括 15923 例患者。中位随访 2.3 年(四分位间距 0.5 至 7.4 年)后,有 5696 例患者死亡。中心性肥胖与死亡率相关(风险比[HR]:1.70,95%置信区间[CI]:1.58 至 1.83),而 BMI 与死亡率呈负相关(HR:0.64,95% CI:0.59 至 0.69)。在 BMI 正常和 BMI≥30kg/m²的患者亚组中,中心性肥胖与更高的死亡率相关(HR:1.70,95% CI:1.52 至 1.89)和(HR:1.93,95% CI:1.61 至 2.32)。

结论

在 CAD 患者中,包括 BMI 正常和较高的患者,中心性肥胖而非 BMI 与死亡率直接相关。

相似文献

1
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data.中心型肥胖与冠心病患者的生存:文献系统评价及个体受试者数据的协作分析。
J Am Coll Cardiol. 2011 May 10;57(19):1877-86. doi: 10.1016/j.jacc.2010.11.058.
2
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
3
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
4
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
5
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
8
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
9
Patient education in the management of coronary heart disease.冠心病管理中的患者教育
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3.
10
Psychological and pharmacological interventions for depression in patients with coronary artery disease.冠心病患者抑郁的心理和药理学干预措施。
Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD008012. doi: 10.1002/14651858.CD008012.pub4.

引用本文的文献

1
In Cardiogenic Shock, Overweight and Obesity Have the Lowest, Whereas Cachexia Has the Highest Mortality.在心源性休克中,超重和肥胖者死亡率最低,而恶病质患者死亡率最高。
J Clin Med. 2025 Jul 25;14(15):5275. doi: 10.3390/jcm14155275.
2
Androgen Receptor PROTAC ARV-110 Ameliorates Metabolic Complications in a Mouse Model of Polycystic Ovary Syndrome.雄激素受体PROTAC ARV-110改善多囊卵巢综合征小鼠模型的代谢并发症。
Endocrinology. 2025 May 19;166(7). doi: 10.1210/endocr/bqaf091.
3
Lower early mortality and risk prediction improvement of obesity after acute pulmonary embolism: results from a multicenter cohort analysis with external validation.
急性肺栓塞后肥胖患者早期死亡率降低及风险预测改善:一项多中心队列分析及外部验证结果
Res Pract Thromb Haemost. 2025 Feb 28;9(2):102718. doi: 10.1016/j.rpth.2025.102718. eCollection 2025 Feb.
4
Beyond body mass index: exploring the role of visceral adipose tissue in intensive care unit outcomes.超越体重指数:探索内脏脂肪组织在重症监护病房结局中的作用。
BJA Open. 2025 Mar 27;14:100391. doi: 10.1016/j.bjao.2025.100391. eCollection 2025 Jun.
5
A systematic review of the impact of Elexacaftor/Tezacaftor/Ivacaftor on body composition in people with cystic fibrosis.依列卡福妥/替扎卡福妥/依伐卡托对囊性纤维化患者身体成分影响的系统评价
Eur J Clin Nutr. 2025 Mar 22. doi: 10.1038/s41430-025-01589-y.
6
Integrated Multivariate Predictive Model of Body Composition and Lipid Profile for Cardiovascular Risk Assessment.用于心血管风险评估的身体成分和血脂谱综合多变量预测模型
J Clin Med. 2025 Jan 25;14(3):781. doi: 10.3390/jcm14030781.
7
Body mass index is similar to alternative anthropometric indices in evaluating plasma lipids as proxy for cardiovascular disease in women with previous hypertensive disorders of pregnancy: A cross-sectional study.在评估既往有妊娠高血压疾病的女性血浆脂质作为心血管疾病替代指标方面,体重指数与其他人体测量指标相似:一项横断面研究。
Womens Health (Lond). 2025 Jan-Dec;21:17455057241310316. doi: 10.1177/17455057241310316.
8
Correlation between weight-adjusted waist index and coronary heart disease: NHANES 1999-2020.体重调整腰围指数与冠心病之间的相关性:1999 - 2020年美国国家健康与营养检查调查
Front Cardiovasc Med. 2025 Jan 10;11:1445802. doi: 10.3389/fcvm.2024.1445802. eCollection 2024.
9
Neck circumference, waist-to-height ratio, Chinese visceral adiposity index and incident heart failure.颈围、腰高比、中国内脏肥胖指数与心力衰竭事件。
Nutr J. 2024 Nov 28;23(1):149. doi: 10.1186/s12937-024-01048-7.
10
Development and validation of a risk score for detecting non-alcoholic fatty liver disease.开发和验证一种用于检测非酒精性脂肪性肝病的风险评分。
Medicine (Baltimore). 2024 Nov 15;103(46):e40417. doi: 10.1097/MD.0000000000040417.